A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 27,453 shares of INCY stock, worth $2.21 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,453
Previous 24,553 11.81%
Holding current value
$2.21 Million
Previous $1.49 Million 21.91%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $166,257 - $198,969
2,900 Added 11.81%
27,453 $1.81 Million
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $73,392 - $91,417
1,434 Added 6.2%
24,553 $1.49 Million
Q1 2024

May 09, 2024

BUY
$56.55 - $66.59 $178,584 - $210,291
3,158 Added 15.82%
23,119 $1.32 Million
Q4 2023

Feb 07, 2024

BUY
$52.16 - $64.19 $242,491 - $298,419
4,649 Added 30.36%
19,961 $1.25 Million
Q3 2023

Nov 08, 2023

BUY
$57.77 - $65.93 $161,524 - $184,340
2,796 Added 22.34%
15,312 $884,000
Q2 2023

Jul 28, 2023

SELL
$60.95 - $75.51 $138,356 - $171,407
-2,270 Reduced 15.35%
12,516 $779,000
Q1 2023

May 10, 2023

BUY
$70.23 - $86.01 $76,269 - $93,406
1,086 Added 7.93%
14,786 $1.07 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $5,643 - $7,065
84 Added 0.62%
13,700 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $58,238 - $72,916
880 Added 6.91%
13,616 $907,000
Q2 2022

Aug 09, 2022

BUY
$66.18 - $83.18 $329,245 - $413,820
4,975 Added 64.1%
12,736 $968,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $488,019 - $589,216
-7,392 Reduced 48.78%
7,761 $616,000
Q4 2021

Feb 23, 2022

BUY
$63.34 - $74.11 $959,791 - $1.12 Million
15,153 New
15,153 $1.11 Million
Q3 2021

Nov 09, 2021

SELL
$68.67 - $84.02 $309,839 - $379,098
-4,512 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $360,373 - $394,935
4,512 New
4,512 $380,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.